切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2012, Vol. 01 ›› Issue (03) : 157 -161. doi: 10.3877/cma.j.issn.2095-3232.2012.03.003

所属专题: 文献

临床研究

经肝门板半肝阻断在肝细胞肝癌切除术中的应用研究
李清汉1, 甄作均1,(), 陈应军1, 陈焕伟1, 计勇1   
  1. 1. 528000 广东,佛山市第一人民医院肝脏胰腺外科
  • 收稿日期:2012-08-07 出版日期:2012-12-10
  • 通信作者: 甄作均

Application of hemihepatic vascular occlusion through hilar plate in resection of hepatocellular carcinoma

Qing-han LI1, Zuo-jun ZHEN1,(), Ying-jun CHEN1, Huan-wei CHEN1, Yong JI1   

  1. 1. Department of Hepatic Surgery and Pancreatic Surgery, The First People’s Hospital of Foshan, Guangdong 528000, China
  • Received:2012-08-07 Published:2012-12-10
  • Corresponding author: Zuo-jun ZHEN
  • About author:
    Corresponding author: ZHEN Zuo-jun, Email:
引用本文:

李清汉, 甄作均, 陈应军, 陈焕伟, 计勇. 经肝门板半肝阻断在肝细胞肝癌切除术中的应用研究[J]. 中华肝脏外科手术学电子杂志, 2012, 01(03): 157-161.

Qing-han LI, Zuo-jun ZHEN, Ying-jun CHEN, Huan-wei CHEN, Yong JI. Application of hemihepatic vascular occlusion through hilar plate in resection of hepatocellular carcinoma[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2012, 01(03): 157-161.

目的

探讨经肝门板半肝阻断在肝细胞肝癌(肝癌)切除术中的应用价值。

方法

本组回顾性研究对象为2007年6月至2012年6月在广东佛山市第一人民医院行肝癌切除术的72例患者。患者均签署知情同意书,符合医学伦理学规定。按肝血流阻断方法将患者分为经肝门板半肝血流阻断组(半肝阻断组)和Pringle肝门血流阻断组(Pringle组)。半肝阻断组30例,男性25例,女性5例,中位年龄42岁;手术方式包括左半肝切除术8例,左外叶切除术2例,右半肝切除术12例,肝右前叶切除术3例,肝右后叶切除术5例。Pringle组42例,男性35例,女性7例,中位年龄45岁;手术方式包括左半肝切除术11例,肝左外叶切除术3例,右半肝切除术18例,肝右前叶切除术2例,右后叶切除术8例。记录手术时间、肝门阻断时间,术中出血量及术后住院时间,观察术后1、3、7 d血清丙氨酸转氨酶(ALT)、白蛋白(ALB)、总胆红素(TB)的变化及术后出血、肝衰竭、胆漏、腹水等并发症及死亡发生情况。采用t检验比较两组手术时间、肝门阻断时间、术中出血量、术后肝功能及术后住院时间的差异。

结果

半肝阻断组和Pringle组患者手术时间分别为(221±51)min和(211±41)min,两组比较差异无统计学意义(t=1.576,P=0.122);半肝阻断组患者肝门阻断时间为(34.5±3.4)min,明显长于Pringle组的(24.0±2.5)min(t=2.541,P=0.015);半肝阻断组和Pringle组患者术中出血量分别为(466±91)ml和(403±80)ml,两组比较差异无统计学意义(t=1.013,P=0.331)。半肝阻断组患者术后1、3、7 d的血清ALB高于Pringle组,ALT、TB低于Pringle组,两组比较差异有统计学意义(均为P<0.05)。半肝阻断组术后住院时间为(6.7±1.3)d,Pringle组为(8.5±2.6)d,两组比较差异有统计学意义(t=2.447,P=0.018)。两组均无发生手术相关死亡及出血、肝衰竭等严重并发症。Pringle组术后1例发生胆漏,21 d后才拔除引流管,治愈;1例术后出现大量腹水,予以补充人血白蛋白及利尿治疗后消失。

结论

在肝癌切除术中应用经肝门板半肝血流阻断具有肝功能损害轻、术后恢复快、并发症发生率低等优点,是一种安全、有效的控制肝脏血流的方法。

Objective

To investigate the application value of hemihepatic vascular occlusion through hilar plate during hepatectomy for patients with hepatocellular carcinoma.

Methods

Retrospective analysis was conducted in 72 patients with hepatocellular carcinoma who underwent hepatectomy from June 2007 to June 2012 in the First People’s Hospital of Foshan. Local ethical committee approval had been received and that the informed consent of all participating subjects was obtained. All the patients were divided into hemihepatic occlusion group and Pringle maneuver group according to the method of vascular occlusion. Thirty cases(25 male, 5 female, mean age of 42 years) were included in the hemihepatic occlusion group, in which, hepatectomy was performed on the left half liver(n=8), left lateral lobes (n=2), right lobe(n=12), right anterior lobes (n=3), right posterior lobes (n=5), respectively. Forty-two cases(35 male, 7 female, mean age of 45 years) were included in the Pringle maneuver group, in which, hepatectomy was performed on the left half liver (n=11), left lateral lobes (n=3), right half liver(n=18), right anterior lobes (n=2), right posterior lobes (n=8), respectively. The time of operation, porta hepatis clamping, blood loss during operation, postoperative hospital stay were recorded. Alanine aminotransferase(ALT), albumin(ALB) and total bilirubin(TB) on day 1, 3, and 7 after operation were monitored. Mortality and postoperative complications including hemorrhage, hepatic failure, bile leakage and seroperitoneum were also detected. The t test was made to compare the difference between two groups in the time of operation, porta hepatis clamping, blood loss during operation, postoperative hepatic function and hospital stay.

Results

The operation time of the hemihepatic occlusion group and Pringle maneuver group were (221±51) min and (211±41) min respectively. There was no significant difference between two groups (t=1.576, P=0.122) . The time of porta hepatis clamping in the hemihepatic occlusion group was (34.5±3.4) min, which was evidently longer than that of the Pringle maneuver group was (24.0±2.5) min (t=2.541, P=0.015). The blood loss during operation in two groups were (466±91) ml and (403±80) ml respectively. There was no significant difference (t=1.013, P=0.331) . The ALB on day 1, 3, and 7 after operation in the hemihepatic occlusion group were higher than that in the Pringle maneuver group while the ALT, TB were lower than those in the Pringle maneuver group. There was no significant difference between two groups (all in P<0.05). The hospital stay in two groups were (6.7±1.3) d and (8.5±2.6) d, which demonstrated significant difference (t=2.447, P=0.018) . No mortality, hemorrhage or hepatic failure was found in two groups. One case in the Pringle maneuver group suffered bile leakage after the operation and were cured by removing the drainage tube 21 days later. And 1 case suffered massive ascites and recovered by the use of albumin and diuretics.

Conclusions

The hemihepatic vascular occlusion through hilar plate in hepatectomy of hepatocellular carcinoma is a safe and effective technique for controlling the hepatic blood flow, with the advantage of less damage to liver function, quick recovery after operation and low incidence of complicatons.

表1 半肝阻断组和Pringle组患者手术情况比较(±s
表2 半肝阻断组和Pringle组患者术前及术后不同时间肝功能变化比较(±s
[1]
严律南,曾勇,林琦远,等.半肝血流阻断下肝能量代谢变化的研究.中华肝胆外科杂志, 2000, 6(1):10-12.
[2]
严律南,袁朝新,张肇达,等.应用半肝血流阻断行肝叶切除术29例报告.中华外科杂志, 1994, 32(1):35-36.
[3]
Makuuchi M, Mori T, Gunvén P, et al. Safety of hemihepatic vascular occlusion during resection of the liver. Surg Gynecol Obstet, 1987, 164(2):155-158.
[4]
陈孝平,张志伟.常温下肝门阻断对肝细胞功能的影响.肝胆外科杂志, 1995, 3(1):6-7.
[5]
吴阶平,裘法祖.黄家驷外科学[M]. 4版.北京:人民卫生出版社, 1986: 1198-1220.
[6]
吴孟超,陈汉,张晓华,等.外科治疗原发性肝癌1102例.第二军医大学学报, 1993, 14(3):201-204.
[7]
汤钊猷,余业勤,周信达,等. 1450例原发性肝癌的外科治疗.中华外科杂志, 1992, 30(6):325-328.
[8]
李基业,WeglinskiKupiec.钙蛋白酶与肝移植缺血再灌注损伤关系的实验研究.中华肝胆外科杂志, 2002, 8(5):287-289.
[9]
Chau GY, Lui WY, King KL, et al. Evaluation of effect of hemihepatic vascular occlusion and the Pringle maneuver during hepatic resection for patients with hepatocellular carcinoma and impaired liver function. World J Surg, 2005, 29(11):1374-1383.
[10]
夏锋,王曙光,别平,等. Pringle法导致的肝脏缺血再灌注损伤对肝癌肝切除患者预后的影响.中华消化外科杂志, 2009, 8(2):103-106.
[11]
乔治,李荣,黎沾良,等.半肝与全肝入肝血流阻断下肝切除术后肠道细菌易位影响对比研究.中国实用外科杂志, 2008, 28(10):878-879.
[12]
Kaneko H, Tamura A, Ishii T, et al. Bacterial translocation in small intestinal ischemia-reperfusion injury and efficacy of Anti-CINC antibody treatment. Eur Surg Res, 2007, 39(3):153-159.
[13]
Fu SY, Lau WY, Li GG, et al. A prospective randomized controlled trial to compare Pringle maneuver, hemihepatic vascular inflow occlusion, and main portal vein inflow occlusion in partial hepatectomy. Am J Surg, 2011, 201(1):62-69.
[14]
严律南.肝门板及其在肝胆外科的应用.中国普外基础与临床杂志, 1998, 5(4):239.
[15]
Lau WY, Lai EC, Lau SH. Methods of vascular control technique during liver resection: a comprehensive review. Hepatobiliary Pancreat Dis Int, 2010, 9(5):473-481.
[16]
孔凡民,董明,田雨霖.肝门板分离技术在肝胆外科手术中的应用.中国实用外科杂志, 2008, 28(2):151-152.
[17]
刘允怡.肝切除与肝移植应用解剖学[M].北京:人民卫生出版社, 2010: 27-34.
[18]
范国勇,甄作均,陈焕伟,等.腹腔镜经肝门板半肝血流阻断在左半肝切除中的应用[J/CD].消化肿瘤杂志:电子版, 2011, 3(2):78-81.
[19]
刘鹏熙,吕新生,韩明,等.肝门阻断后细菌及内毒素移位的研究.中华实验外科杂志, 1997, 14(1):32-33.
[20]
Liu DL, Jeppsson B, Hakansson CH, et al. Multiple- system organ damage resulting from prolonged hepatic inflow interruption. Arch Surg, 1996, 131(4):442-447.
[1] 王春荣, 陈姜, 喻晨. 循Glisson蒂鞘外解剖、Laennec膜入路腹腔镜解剖性左半肝切除术临床应用[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 37-40.
[2] 索郎多杰, 高红桥, 巴桑顿珠, 仁桑. 腹腔镜下不同术式治疗肝囊型包虫病的临床疗效分析[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 670-673.
[3] 汤海琴, 郭秀枝, 朱晓素, 赵世娣. “隧道法”腹腔镜解剖性左半肝切除术的临床安全性研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 674-677.
[4] 杜锡林, 谭凯, 贺小军, 白亮亮, 赵瑶瑶. 肝细胞癌转化治疗方式[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 597-601.
[5] 魏小勇. 原发性肝癌转化治疗焦点问题探讨[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 602-607.
[6] 张其坤, 商福超, 李琪, 栗光明, 王孟龙. 联合脾切除对肝癌合并门静脉高压症患者根治性切除术后的生存获益分析[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 613-618.
[7] 严庆, 刘颖, 邓斐文, 陈焕伟. 微血管侵犯对肝癌肝移植患者生存预后的影响[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 624-629.
[8] 段文忠, 白延霞, 徐文亭, 祁虹霞, 吕志坚. 七氟烷和丙泊酚在肝切除术中麻醉效果比较Meta分析[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 640-645.
[9] 张文华, 陶焠, 胡添松. 不同部位外生型肝癌临床病理特点及其对术后肝内复发和预后影响[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 651-655.
[10] 韩宇, 张武, 李安琪, 陈文颖, 谢斯栋. MRI肝脏影像报告和数据系统对非肝硬化乙肝患者肝细胞癌的诊断价值[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 669-673.
[11] 唐灿, 李向阳, 秦浩然, 李婧, 王天云, 柯阳, 朱红. 原发性肝脏神经内分泌肿瘤单中心12例诊治与疗效分析[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 674-680.
[12] 张维志, 刘连新. 基于生物信息学分析IPO7在肝癌中的表达及意义[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 694-701.
[13] 陈安, 冯娟, 杨振宇, 杜锡林, 柏强善, 阴继凯, 臧莉, 鲁建国. 基于生物信息学分析CCN4在肝细胞癌中表达及其临床意义[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 702-707.
[14] 叶文涛, 吴忠均, 廖锐. 癌旁组织ALOX15表达与肝癌根治性切除术后预后的关系[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 708-712.
[15] 吴晨瑞, 廖锐, 贺强, 潘龙, 黄平, 曹洪祥, 赵益, 王永琛, 黄俊杰, 孙睿锐. MDT模式下肝动脉灌注化疗联合免疫靶向治疗肝细胞癌多处转移一例[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 713-716.
阅读次数
全文


摘要